Switching between weight-loss medications This article proposes practical approaches for safe, effective switching between tirzepatide and semaglutide.…
Health news round-up: coffee, ADHD prescribing, and GLP-1s and hair loss The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
Novo Nordisk sues Eli Lilly over ‘misleading’ GLP-1 advertising Novo Nordisk claims that Lilly’s advertising campaigns intentionally used outdated studies to offer “proof of broad, product-level superiority” of its Zepbound and Mounjaro products over Novo Nordisk’s Wegovy and Ozempic products.…
PJ view: Patients deserve a regulatory system built to keep them safe as oral semaglutide launches Regulators have taken welcome steps to tackle counterfeit weight-loss medicines, but patients cannot be left to police this market alone.…
GPhC launches campaign on risk of fake online pharmacies following launch of oral semaglutide The General Pharmaceutical Council has created posters and videos to educate patients on how to spot a fake online pharmacy.…
Regulator takes action against Tesco weight-loss advertising The Medicines and Healthcare products Regulatory Agency said that the supermarket pharmacy had amended its advertising to ensure that prescription-only medicines for weight loss were not promoted to the public.…
Three-quarters of pharmacies expect surge in demand for weight-loss pill National Pharmacy Association says the availability of oral semaglutide (Wegovy; Novo Nordisk) “is particularly significant for patients who cannot or do not want to take an injectable medicine”.…
Health news round-up: relabelling prostate cancer, zoonotic diseases and e-cigarette chemicals The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
Everything you need to know about GLP-1s for weight loss From semaglutide to tirzepatide, this article collates the latest information on pharmacological weight-loss treatments, including evidence and best practice for their use.…
Health news round-up: contraception, obesity inequalities and eating disorders on GLP-1s The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
